Use of gelvisol in the preparation of patients with toxic goiter for surgery
Zarivchatskiĭ, M.F.
Vestnik Khirurgii Imeni I. I. Grekova 131(12): 12-14
1983
ISSN/ISBN: 0042-4625 PMID: 6689454 Document Number: 205155
Results of the application of gelvisol in 74 patients with toxic goiter enabled the author to recommend the drug to be included in the preoperative preparing of the patients along with other usual medication. The effect of gelvisol caused quicker normalization of functions of main organs and systems.
Document emailed within 1 workday
Related Documents
Ianchur, N.M.; Pavlenko, V.N. 1974: Use of anabolic steroids in the preoperative preparation of patients with toxic goiter Vestnik Khirurgii Imeni I. I. Grekova 112(3): 31-33Kariakin, A.M.; Kotova, S.M.; Kofman, B.L.; Kucher, V.V.; Alesov, V.Z. 1984: Use of extracorporeal hemosorption for the preoperative preparation of toxic goiter patients Vestnik Khirurgii Imeni I. I. Grekova 133(12): 78-80
Cheren'ko, M.P. 1972: Development of primary diffuse toxic goiter in a patient previously subjected to surgery for euthyroid nodular goiter Klinicheskaia Khirurgiia 9: 72-73
Reznichenko, A.M. 2003: Plasma fibronectin in patients during toxic goiter surgery and early postoperative period Klinichna Khirurhiia 9: 38-40
Lambrecht, W.; Raiński, J.; Zgrych, J.; Szmidt, M. 1985: Diagnostic methods in the evaluation of thyroid gland function in patients with goiter during preparation for surgery Wiadomosci Lekarskie 38(8): 584-588
Rajatanavin, R.; Pitchayayothin, N.; Kongsuksai, A.; Choksuwattanasakul, P.; Himathongkam, T. 1988: Autoimmune thyroiditis in patients with non-toxic goiter Journal of the Medical Association of Thailand 71(12): 659-665
Epishin, A.V. 1979: Immunological indices in patients with toxic goiter Klinicheskaia Meditsina 57(1): 91-93
Dlugach, E.A.; Aleksandrova, G.F.; Mel'nichenko, G.A. 1993: Principles of training patients with diffuse toxic goiter Problemy Endokrinologii 39(4): 31-33
Sekhniashvili, Z.S. 1988: Immunological characteristics of patients with diffuse toxic goiter Problemy Endokrinologii 34(2): 3-5
Rom-Bugoslavskaia, E.S.; Somova, E.V.; Grinchenko, T.S.; Kravchun, N.A.; Romanova, I.P.; Mishura, A.I. 1998: Lipid peroxidation in patients with diffuse toxic goiter and hypothyroidism Likars'ka Sprava 1: 88-91
Petrov, N.M. 1986: Lithium carbonate in the treatment of patients with diffuse toxic goiter Vrachebnoe Delo 6: 64-66
Greĭser, A.E.; Fomin, L.M. 1972: The electrocardiogram in the treatment of toxic goiter patients with thyrostatic drugs Klinicheskaia Meditsina 50(8): 95-98
Skripnichenko, D.F.; Krivitskiĭ, D.I. 1983: Differentiated volume of thyroid gland resection in toxic goiter patients Klinicheskaia Khirurgiia 1983(12): 29-32
Kryshkova, A.M.; Kharizanova, M.S.; Dishliev, V.D. 1970: Blood pyruvic acid levels in patients with nontoxic and toxic goiter Problemy Endokrinologii 16(3): 15-17
Epishin, A.V. 1984: Immunologic reactions in patients with diffuse toxic goiter after mercasolyl treatment Klinicheskaia Meditsina 62(8): 90-93
Derwahl, M. 1999: Mutations in the thyrotropin receptor gene in the pathogenesis of toxic thyroid adenomas, toxic goiter nodules and autosomal dominant hyperthyroidism Zeitschrift für Arztliche Fortbildung und Qualitatssicherung 93(Suppl 1): 25-28
Rybiński, K.; Kuzdak, K. 1984: Changes in the levels of thyrotropin and thyroid hormones in patients after strumectomy in non-toxic nodular goiter Endokrynologia Polska 35(6): 365-371
Livshits, A.Kh.; Oleĭnik, E.K. 1985: Changes in the immune status indices of patients with diffuse toxic goiter in different stages of the disease Problemy Endokrinologii 31(6): 6-10
Gracheva, K.P.; Odinokova, V.A. 1970: Clinico-morphologic comparisons in 2-stage strumectomy in patients with acute toxic goiter Vestnik Khirurgii Imeni I. I. Grekova 105(12): 21-23
Baranov, V.G.; Potin, V.V.; Stepanov, G.S.; Shliakhtina, L.G. 1970: Characteristics of the biological effect of the thyrotropic activity of the blood of diffuse toxic goiter patients Problemy Endokrinologii 16(6): 27-33